go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Organon Laboratories Limited
(Merck Sharp & Dohme Ireland (Human Health) Limited), P.O. Box 2857, Drynarn Road, Swords, Co Dublin, Ireland
Telephone: +353 1 299 8700
Fax: +353 1 299 8701
Medical Information e-mail: medinfo_ireland@merck.com
Summary of Product Characteristics last updated on medicines.ie: 19/07/2011
SPC Marviol

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 19/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   31-Jan-2010
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company


Change to section 4.2 - Posology and method of administration
Change to section 4.3 - Contraindications

 Change to section 4.4 - Special warnings and precautions for use

 Change to section 4.5 – Interaction with other medicinal products and other forms of interaction

 Change to section 4.8 - Undesirable effects

 Change to section 5.1 - Pharmacodynamic properties

Change to section 9 - Date of first authorisation/Renewal of  authorisation

 Change to section 10 - Date of revision of the text
Updated on 25/03/2009 and displayed until 19/07/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 14/08/2008 and displayed until 25/03/2009
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4 - Clinical particulars
  • Change to section 5 - Pharmacological properties
  • Change to section 6 - Pharmaceutical particulars
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   02/2008
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company
Section 2- slight re-wording of text
Section 3- slight re-wording of text
Section 4- all clinical sections amended to include uptodate information inline with company core data sheet
Section 5- all clinical sections amended to include uptodate information inline with company core data sheet
Section 6- slight re-wording of text
Section 10- date of revision of text updated
Updated on 31/07/2006 and displayed until 14/08/2008
Reasons for adding or updating:
  • Change to section 9 - Date of renewal of authorisation
  • Correction of spelling/typing errors
Date of revision of text on the SPC:   01/2004
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company
Section 9 - update to date of renewal of the authorisation 
 
Correction of typographical error (section 4.8)
Updated on 04/06/2004 and displayed until 31/07/2006
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.1 - List of excipients
  • Change to section 6.2 - Incompatibilities
  • Change to section 10 - Date of revision of the text
Updated on 20/06/2003 and displayed until 04/06/2004
Reasons for adding or updating:
  • New SPC for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Ethinyloestradiol
  Desogestrel